drugset / Trial / NCT01984580
Effect of Zinc on Barrett's Metaplasia
RandomizedParallel-groupSingle-blindPrevention
Summary
Using orally administered zinc to patients already diagnosed with the pre-cancerous condition, Barrett's Esophagus, this study is asking two questions: 1. can this zinc administration cause molecular-level changes in the Barrett's tissue? 2. are the changes measured indicative of chemopreventive action by zinc regarding cancer progression?
Timeline
- Start
- 2011-04
- Primary completion
- 2015-03
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinc gluconate | Small molecule | 26.6 mg | Oral |